BTK and COVID-19: Interestingly, some agents were found to have anti-cytokine storm effects, which have shown promise in patients with COVID-19 (e.g., the Janus kinase (JAK) inhibitors and Bruton’s tyrosine kinase (BTK) inhibitors) [17, 18].